Elmind Capital »

Vaxcyte shares owned by Elmind Capital

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 317k 58.11

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte